![Phillip Chan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Phillip Chan
Algemeen Directeur bij
CYTOSORBENTS CORPORATION
Vermogen: 652 418 $ op 30-06-2026
Profiel
Phillip P.
Chan was the founder of Andrew Technologies LLC, founded in 2006, where the title held was Director from 2010 to 2011.
Dr. Chan is the founder of CytoSorbents Europe GmbH, founded in 2012, holding the title of Co-Managing Director since 2012.
Dr. Chan currently works at CytoSorbents Corp.
as Chief Executive Officer & Director since 2020, with employment starting in 2008.
Former jobs include Partner at Tech Council Ventures LLC.
Education includes undergraduate studies at Cornell University and a doctorate from Yale School of Medicine.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 15-06-2026 | 1.744.432 ( 2,78% ) | 652 418 $ | 30-06-2026 |
Actieve functies van Phillip Chan
| Bedrijven | Functie | Begin |
|---|---|---|
| CYTOSORBENTS CORPORATION | Algemeen Directeur | 24-07-2008 |
CytoSorbents Europe GmbH
 CytoSorbents Europe GmbH Medical DistributorsDistribution Services Sells pharmaceutical products, medical and orthopaedic articles | Algemeen Directeur | 01-02-2012 |
Eerdere bekende functies van Phillip Chan
| Bedrijven | Functie | Einde |
|---|---|---|
Tech Council Ventures LLC
 Tech Council Ventures LLC Investment ManagersFinance Tech Council Ventures invests in companies located across the globe. The firm focuses across a board range of sectors and industries. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.5 to 5 million. The firm takes board seat and acts as lead investor. | Private Equity Investor | 30-06-2009 |
Andrew Technologies LLC
 Andrew Technologies LLC Medical SpecialtiesHealth Technology Operates as an early stage medical device company | Oprichter | - |
Opleiding van Phillip Chan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
31
Eerstegraads connecties
6
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 6 |
|---|---|
Tech Council Ventures LLC
Tech Council Ventures LLC Investment ManagersFinance Tech Council Ventures invests in companies located across the globe. The firm focuses across a board range of sectors and industries. It provides financing for seed and early stage capital requirements with an investment size ranging from USD 0.5 to 5 million. The firm takes board seat and acts as lead investor. | Finance |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CytoSorbents Corp.
 CytoSorbents Corp. Medical SpecialtiesHealth Technology Develops products to support healthcare professionals in the treatment of complex medical conditions | Health Technology |
Andrew Technologies LLC
Andrew Technologies LLC Medical SpecialtiesHealth Technology Operates as an early stage medical device company | Health Technology |
CytoSorbents Europe GmbH
CytoSorbents Europe GmbH Medical DistributorsDistribution Services Sells pharmaceutical products, medical and orthopaedic articles | Distribution Services |
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
